Post-Menopause: The Health Screenings You Need Now

For most of your adult life, your screening calendar was simple. A pap smear every few years. A mammogram starting at 40 or so. An annual physical with basic blood work. Maybe a quick conversation about birth control, fertility, or family history. The system was built around your reproductive years, and it mostly worked.

Post-menopause is a different risk window. The biggest threats to your health and longevity in your 60s and 70s are not the same threats you were screened for in your 30s. Heart disease, fragility fractures, colorectal and lung cancer, type 2 diabetes, dementia, and a small handful of post-menopausal cancers now top the list. Your annual visit needs to evolve to match.

The frustrating reality is that many primary care clinics have not fully made that pivot. Visits are short. Order sets default to the basics. The high-yield tests are sometimes left off the standard menu, and the patient is the one expected to know to ask. This article is the ask list. Walk in with it, and you will get the kind of midlife and post-menopausal screening that actually moves the needle.

Why post-menopause is a different screening era

Three things shift the screening picture once you cross the menopause threshold.

First, the protective effect of estrogen on your cardiovascular system, your skeleton, and several metabolic systems is gone. Conditions that were quietly held at bay for thirty years now begin to emerge.

Second, time-related risks compound. Cancers that take decades to develop, like colorectal cancer and certain lung cancers, are reaching the window where they become detectable and treatable. Vascular disease that was forming silently in your 40s is becoming clinically meaningful.

Third, several screening tests that were not particularly useful in your 30s become very useful in your 60s. Bone density scans, coronary artery calcium scoring, colonoscopy, and a wider lipid panel all earn their place in the post-menopausal era. The modern best-practice screening calendar reflects that shift, but a generic primary care visit may not.

Cardiovascular screening: the highest-yield category

Cardiovascular disease is the leading cause of death in post-menopausal women, and it is the area where modern screening has the most to offer. The basics are not enough.

Full lipid panel with ApoB and Lp(a). A standard total cholesterol and LDL panel misses meaningful information. ApoB measures the actual number of atherogenic particles circulating in your blood, and it is a better predictor of cardiovascular events than LDL alone. Lipoprotein(a), or Lp(a), is a genetically determined risk factor that should be measured at least once in your lifetime, ideally before or during menopause. Both are inexpensive. Both are often left off the default order set. Ask for them by name.

Blood pressure done right. A single in-office reading at the start of an appointment is not adequate. The proper protocol is seated for five minutes, with the right cuff size, with feet flat, and confirmed across at least two visits. If your numbers are borderline or rising, ask for a 14-day home monitoring stretch. White-coat effects can falsely elevate or falsely reassure, and home monitoring tells the truth.

Coronary artery calcium (CAC) scan. This is the single most underused gem in post-menopausal cardiovascular screening. A CAC scan is a low-dose CT that takes about five minutes, costs roughly $100 in most regions, and tells you whether plaque is already forming in the arteries that feed your heart. A score of zero is profoundly reassuring. A non-zero score allows for a precise, evidence-based prevention conversation. It is reasonable for any post-menopausal woman with a family history, rising lipids, hypertension, or any other risk factor.

Hemoglobin A1c and fasting insulin. Type 2 diabetes risk climbs at menopause, and pre-diabetes often hides behind a normal fasting glucose. A1c captures three-month average blood sugar. Fasting insulin (with a glucose) lets your clinician calculate insulin sensitivity. These two tests catch metabolic dysfunction five to ten years earlier than fasting glucose alone.

High-sensitivity CRP. A measure of low-grade inflammation. Useful for refining cardiovascular risk in borderline cases.

Carotid ultrasound or ankle-brachial index, selectively. If your CAC is non-zero, your blood pressure is hard to control, or your family history is striking, additional vascular imaging may be warranted.

Bone density and fracture risk

Up to 20 percent of the bone you lose in your lifetime comes off in the first five to seven years after menopause. After that, the rate slows but continues. By your late 60s, one in three women has osteoporosis, and most do not know it until they break something.

DEXA scan starting at age 65, earlier if you have risk factors. The dual-energy X-ray absorptiometry scan measures bone density at the hip and spine, the two most fracture-prone sites. It takes 15 minutes, is painless, uses minimal radiation, and is covered by Medicare and most insurance every two years. If you are post-menopausal with a family history of fracture, low body weight, prior steroid use, an early menopause, or any prior fragility fracture, ask for a DEXA earlier than 65.

FRAX score. The Fracture Risk Assessment Tool combines your DEXA results with clinical risk factors to estimate your 10-year probability of a major osteoporotic fracture. A FRAX score above the treatment threshold is what triggers a serious conversation about bisphosphonates, denosumab, anabolic agents, or HRT. Without a FRAX, the DEXA number alone can mislead.

Vitamin D level. Inadequate vitamin D limits calcium absorption and undermines bone health. Most post-menopausal women benefit from supplementation, and a baseline 25-hydroxyvitamin D level guides dosing.

Calcium and protein adequacy. Not strictly a screening test, but worth a conversation. Most post-menopausal women under-eat both. A combined target of about 1,200 mg of calcium per day from food first, with supplementation only if needed, and 1.0 to 1.2 grams of protein per kilogram of body weight, is a reasonable starting point.

Cancer screenings worth keeping current

Several cancers have either rising incidence or better outcomes with early detection in the post-menopausal years.

Mammogram, every one to two years. Continue through age 75 in most current guidelines, longer if you are healthy and likely to live another 10 years. Discuss density-based supplemental imaging if your mammograms repeatedly show dense breast tissue, since dense tissue both raises baseline risk and reduces mammogram sensitivity.

Colonoscopy starting at age 45, then on the schedule your gastroenterologist recommends. Colorectal cancer is the second leading cause of cancer death for women, and it is one of the most preventable cancers we have, because polyps can be removed before they ever become malignant. If you have a family history, your starting age may be earlier. Stool-based screening tests like FIT or Cologuard are reasonable alternatives in some cases, but a positive result still leads to colonoscopy.

Pap smear and HPV testing through age 65. If you have had consistent normal screenings and no high-risk HPV history, your gynecologist may recommend stopping at 65. If you have a history of high-grade abnormalities or a weakened immune system, screening may continue longer. Pelvic exam with vaginal and vulvar inspection is still useful, particularly to catch the slow-onset issues of GSM.

Lung cancer screening with low-dose CT is now recommended annually for women aged 50 to 80 with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. If that fits you, ask for it. It is one of the highest-impact cancer screenings introduced in the past decade and is significantly underused.

Skin cancer check. An annual full-body skin exam by a dermatologist is reasonable if you have a history of significant sun exposure, a personal or family history of skin cancer, or many atypical moles. Melanoma is highly treatable when caught early.

Endometrial monitoring. Any post-menopausal bleeding deserves prompt evaluation, full stop. It is most often benign, but it is the cardinal symptom of endometrial cancer, and the workup (transvaginal ultrasound and often endometrial biopsy) is straightforward. Do not wait.

Thyroid, metabolic, and other often-missed labs

A handful of additional tests have a high yield in post-menopausal women and are easy to add to your standard blood draw.

TSH, with free T4 and TPO antibodies if indicated. Autoimmune thyroid disease is more common in women and tends to surface or worsen during the menopause transition. The symptoms (fatigue, weight gain, brain fog, hair changes, mood shifts) overlap heavily with menopause itself, and women often spend years on a menopause workup when a thyroid panel would have flagged the issue in 10 minutes. Ask for it.

Comprehensive metabolic panel. Standard, but worth doing yearly. Captures kidney and liver function, electrolytes, and fasting glucose.

Complete blood count. Catches anemia, which becomes more common in the post-menopausal years and can drive fatigue that mimics other midlife symptoms.

Iron studies (ferritin, iron, TIBC) selectively. If you are tired, if your nails or hair are changing, or if you had heavy bleeding in the years leading into menopause, low iron stores are a common and easily corrected finding.

Vitamin B12. Absorption decreases with age, particularly if you take a daily proton pump inhibitor or metformin. Deficiency can cause fatigue, neuropathy, and cognitive symptoms that look very much like normal aging.

Pelvic and genitourinary health

Genitourinary syndrome of menopause (GSM) is the slow-onset cluster of vaginal dryness, painful intercourse, urinary urgency, and recurrent UTIs that affects roughly half of post-menopausal women. It is rarely volunteered in a primary care visit, and many women never bring it up themselves.

Your screening prompt list should include a direct conversation about:

• Vaginal dryness and any pain with intercourse
• Urinary urgency, frequency, leakage, or recurrent UTIs
• Pelvic pressure or any sensation of prolapse
• Sexual function, libido, and arousal changes

Vaginal estrogen, vaginal DHEA, and pelvic floor physical therapy are all highly effective and underprescribed. None of them require systemic HRT, and most are very safe long-term.

Mental and cognitive health

Depression, anxiety, and cognitive changes do not stop at the end of the menopause transition, and several of them have specific screening tools that catch problems early.

PHQ-9 and GAD-7 are short questionnaires that screen for depression and anxiety. Many primary care offices use them routinely. If yours does not, ask. Untreated depression in post-menopausal women is associated with worse cardiovascular outcomes, worse bone health, and worse quality of life. It is not "just aging."

Cognitive screening is appropriate if you, your family, or your clinician notices a meaningful change. Tools like the Mini-Cog or MoCA can flag early issues that warrant a fuller workup. Most subjective brain fog in post-menopausal women is not dementia, but a thoughtful early evaluation is worth doing.

Sleep evaluation. If you snore, wake gasping, or are persistently exhausted despite adequate time in bed, ask for a home sleep study. Obstructive sleep apnea rises sharply in post-menopausal women, is dramatically underdiagnosed, and drives blood pressure, weight, mood, and cognition in the wrong direction.

Vision, hearing, dental, and skin

The senses and oral health quietly affect almost every aspect of post-menopausal quality of life.

Annual eye exam, especially after age 60. Glaucoma, cataracts, and macular degeneration all become more common. Many are modifiable or treatable when caught early.

Hearing test every few years. Untreated hearing loss is one of the strongest modifiable risk factors for dementia. The threshold for considering hearing aids has dropped, and over-the-counter options now exist for mild to moderate loss.

Dental cleaning twice a year and a periodontal exam annually. Estrogen loss accelerates bone loss in the jaw, and gum disease is associated with higher cardiovascular risk. Dry mouth from menopause-related changes also raises cavity risk.

Skin self-checks monthly. Watch for new or changing moles, persistent rough patches, or sores that do not heal. Bring anything new to a dermatologist.

Vaccines that matter in post-menopause

The adult vaccine schedule changes in the post-menopausal years. Worth a current conversation with your primary care doctor.

• Shingles (Shingrix), two doses, recommended starting at age 50. Shingles is more common and often more severe in post-menopausal women.
• Pneumococcal vaccines starting at age 50 to 65, depending on risk factors.
• RSV vaccine for adults 60 and older or 75 and older depending on the most current ACIP guidance.
• Annual influenza vaccine.
• Tdap or Td booster every 10 years.
• COVID-19 boosters per the most current recommendations.

The post-menopausal screening calendar at a glance

A reasonable annual rhythm for most healthy post-menopausal women looks like this:

Every year: Blood pressure check (with home monitoring if borderline), full lipid panel with ApoB, A1c, fasting insulin if indicated, comprehensive metabolic panel, CBC, TSH, vitamin D, depression and anxiety screen, GSM and pelvic health conversation, mammogram if on that interval, dermatology check if recommended, dental visits twice yearly.

Every two years: DEXA scan, eye exam (annual after 60), Pap and HPV per current schedule until 65.

Once or as recommended: Lipoprotein(a) at least once, coronary artery calcium scan once with repeat in 5 to 10 years if the first is non-zero, colonoscopy on your gastroenterologist's schedule, lung cancer screening if eligible, hearing test every few years, sleep study if indicated.

This is more than the default order set at most annual physicals. That is the point. The default is built around the average healthy adult, and post-menopausal women are not the average healthy adult anymore. The right screening for this stage of life is a more deliberate ask.

The bottom line

Post-menopause is a screening pivot, not a continuation of what came before. The cardiovascular workup gets more sophisticated, with ApoB, Lp(a), and a coronary artery calcium scan earning a real role. Bone density screening starts. Cancer screenings continue but with new entrants like lung CT for former smokers. Thyroid, metabolic, and pelvic health become higher-yield. Vaccines, sleep, vision, and hearing all earn their seats at the table.

The single most useful thing you can do for your post-menopausal health is walk into your next annual visit with a list of what you want ordered, and a primary care doctor or menopause specialist who takes the list seriously rather than waving it off as "all normal for your age." The interventions that work in this stage of life work very well, and the conditions that hurt women most are largely the ones we know how to find early and treat.

This article is for informational purposes only and does not constitute medical advice. Screening recommendations evolve. Discuss your individual screening plan with a qualified clinician familiar with your personal and family history.